Navigation Links
Egenix, Inc. Announces New Director
Date:11/5/2012

MILLBROOK, N.Y., Nov. 5, 2012 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc., is pleased to announce the appointment of Rainer Fuchs, Ph.D. to its Board of Directors. Dr. Fuchs is a former V.P. of Biogen Idec and currently Chief Information Officer at Harvard Medical School in Cambridge, Massachusetts. Dr. Fuchs will be a substantial asset to the company.  Additionally, the Company has added the following scientist to complete its Drug Development Team: Bob Bishop, Ph.D., Jerry Shipps, Ph.D., Alan Cooper, Ph.D., and Arshad Siddiqui, Ph.D.

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics. The company's therapeutic platform technology consists of small molecule drugs applicable for the treatment and prevention of a broad spectrum of cancers. Our lead drug candidates inhibit the "translation initiation factor" eIF4E, specifically blocking production of multiple cancer promoting proteins and promoting apoptosis (programmed cell death) and upregulation of tumor suppressor genes. The company licensed this technology from Harvard Medical School in 2007. eIF4E is an important cancer therapeutic target because every function necessary for cancer growth and metastasis is influenced or mediated by a gene product that is regulated by this translation initiation factor. Data from human cancer xenograft studies using two of our lead compounds tested against breast cancer and melanoma demonstrated 100% tumor inhibition and 20% to 30% tumor reduction. For more information visit www.egenixinc.com.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
2. WebMD Announces Third Quarter Financial Results
3. Life Technologies Announces Third Quarter 2012 Results
4. HealthTech Capital Announces Awards for the HealthTech Conference 2012 - Building a Business in the New HealthTech Ecosystem
5. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
6. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
7. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
8. Synthetic Biologics Announces $10.8 Million Financing
9. Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split
10. Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
11. Techne Corporation Declares Dividend And Announces An Increase In Its Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Branford, Conn. (PRWEB) , ... September 01, 2015 ... ... development of high-quality recombinant antibodies, announced today that the National Institutes of Health ... grant (1R41DK104602-01), which will be administered by the NIH’s National Institute of Diabetes ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... in the neuro and pain management space join prominent academics and key investors ... Center at Harvard Medical School in Boston. , Neuro Advance Boston focuses ...
(Date:9/1/2015)... ... September 01, 2015 , ... Industry leader iLab ... Pacific. In this newly-created position, Gibbs will lead iLab’s business operations in the ... of tools. This entails not only introducing iLab to potential partners but support ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of a groundbreaking new version of its flagship DNA design ... methodology breaks down complex DNA sequences into numerous genetic parts, which in turn ...
Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2
... Sept. 29, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Bienaime, Chief Executive Officer of BioMarin, will host ... 27, at 5:00 p.m. ET to discuss third ... 877.299.4454International Dial-in Number: 617.597.5447Participant Code: 74745522Replay Dial-in Number: ...
... SAN DIEGO, Sept. 29, 2011 Orexigen® Therapeutics, Inc. ... (naltrexone sustained release (SR)/bupropion SR) abstracts accepted for poster ... Annual Scientific Meeting of The Obesity Society. This meeting ... at the Orlando World Center Marriott. ...
... about your immune system, you probably think about it fighting ... Adelaide suggests that immune cells in your brain may contribute ... think that despite 10,000 years of using alcohol, and several ... nerve cells in our brain, we are still trying to ...
Cached Biology Technology:BioMarin to Host Third Quarter 2011 Financial Results Conference Call and Webcast on Thursday, October 27 at 5:00 p.m. ET 2Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society 2Alcohol-related behavior changes -- blame your immune system 2
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... reducing CO2 levels in the atmosphere by adding lime to ... reverse CO2 accumulation in the atmosphere, reports Cath O,Driscoll in ... Shell is so impressed with the new approach that ... think it,s a promising idea, says Shell,s Gilles Bertherin, a ...
... New research into the treatment of Alzheimer,s disease ... immune-based approach. A video accompanying the research, published ... documents rapid language improvement within minutes of using ... by the same authors, published in BioMed Central,s ...
... study performed by researchers at the Institute for Research ... the Instituto de Biologa Molecular of the CSIC, reveal ... a tissue by regulating cell adhesion. This same mechanism ... its metastasis, when tumour cells lose their adhesion to ...
Cached Biology News:A dash of lime -- a new twist that may cut CO2 levels back to pre-industrial levels 2Discovery of a mechanism that regulates cell movement 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Biology Products: